A Narrative Overview of Active Surveillance for Clinically Localised Prostate Cancer

Medicine & Life Sciences

• Watchful Waiting 100%
• Prostatic Neoplasms 69%
• Patient Selection 15%
• Prostate 9%
• Therapeutics 8%
• Nurses 8%
• Prospective Studies 7%
• Delivery of Health Care 7%
• Biopsy 7%
• Patient Care Team 6%
• Urologists 6%
• Oncologists 6%
• Physiologic Monitoring 6%
• Data Accuracy 6%
• Prostatectomy 5%
• Pathologists 5%
• Practice Guidelines 5%
• Radiologists 5%
• Uncertainty 5%
• Information Storage and Retrieval 5%
• Counseling 4%
• Nursing 4%
• Disease Progression 4%
• Anxiety 4%
• Radiotherapy 4%
• Magnetic Resonance Imaging 3%
• Neoplasms 3%
• Quality of Life 3%
• Guidelines 3%
• Safety 3%
• Growth 2%